知镜 Cognispect · 医学文献与研究工作台

Time-course blood transcriptome dynamics of TNF-α inhibitor therapy in a Chinese cohort with psoriasis.

Xia Z, Liu L, Wang T, Xue Y, Liu J, Yu D, Hu H, Chen Q, Chu X, Peng R, Liu L, Wang J, Cheng H, Fang H, Zheng M, Yin X, Ren Y.
The Journal of investigative dermatology · 2026-09-09 · PMID 42716213

文献摘要

TNF-α inhibitors are effective biologics for immune-mediated inflammatory diseases, including plaque psoriasis and inflammatory bowel disease. However, time-course peripheral blood transcriptomic changes during treatment remain poorly characterized. To characterize transcriptomic changes associated with TNF-α inhibitor treatment, we profiled blood transcriptomics at 3 time points in 86 patients with plaque psoriasis receiving a TNF-α inhibitor. We identified 3351 time-course drug-response genes that were enriched in immune signaling and cell activation pathways and expressed in psoriatic skin lesions and blood. Among them, 259 genes were differentially expressed between at least 1 pair of the 3 sampling time points, and 962 were shared between psoriasis and inflammatory bowel disease. TNF-α inhibitor responders showed higher expression of OLIG1, LRRK1, and KSR1 and lower expression of TNFAIP3 and MPP7 than nonresponders. We identified a "red" gene coexpression module that was negatively correlated with treatment outcome and enriched in inflammation and TNF-related pathways. High expression of TNFSF10 (the top hub gene of the "red" module) was associated with a poor outcome. By week 2, the red module's coexpression pattern had changed significantly in responders but not in nonresponders. This study characterizes the time-course peripheral blood transcriptional programs of TNF-α inhibitor therapy in plaque psoriasis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。